Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.120
-0.010 (-0.88%)
At close: Jun 26, 2026, 4:00 PM EDT
1.090
-0.030 (-2.68%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $100.24 million as of June 26, 2026. Its market cap has increased by 409.75% in one year.
Market Cap
100.24M
Enterprise Value
69.57M
1-Year Change
409.75%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $100.24M, a decrease of -60.91%. That is a compound annual growth rate of -18.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 100.24M | -15.89% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 104.50M |
| Cibus | 103.81M |
| Vivani Medical | 103.48M |
| Kalaris Therapeutics | 102.78M |
| Cue Biopharma | 102.72M |
| Pelthos Therapeutics | 100.90M |
| Alps Group | 100.84M |
| Black Diamond Therapeutics | 97.99M |